Cytoreductive Nephrectomy Following Immune Checkpoint Inhibitor Therapy Is Safe and Facilitates Treatment-free Intervals

Patients with metastatic renal cell cancer (mRCC) who respond to upfront immune checkpoint inhibitor (ICI) combination therapies may be treated with cytoreductive nephrectomy (CN) to remove radiographically viable primary tumors. Early data for post-ICI CN suggested that ICI therapies induce desmopl...

תיאור מלא

מידע ביבליוגרפי

Principais autores:	Daniel D. Shapiro, Jose A. Karam, Logan Zemp, Viraj A. Master, Wade J. Sexton, Ali Ghasemzadeh, Benjamin N. Schmeusser, Facundo Davaro, Taylor Peak, Dattatraya Patil, Surena Matin, Philippe E. Spiess, E. Jason Abel
פורמט:	Artigo
שפה:	Inglês
יצא לאור:	Elsevier 2023-04-01
סדרה:	European Urology Open Science
נושאים:	Cytoreductive nephrectomy Immune checkpoint inhibitor Renal cell carcinoma Complications
גישה מקוונת:	http://www.sciencedirect.com/science/article/pii/S2666168323001052
תגים:	הוספת תג אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!